Table 2.
Effects of categorical variables on median overall survival
| Median OS (months) | 95% CI | P | |
|---|---|---|---|
| Extrahepatic disease | |||
| No | 22 | 4.7–39.3 | 0.763 |
| Yes | 8 | 5.2–10.8 | |
|
| |||
| MELD score | |||
| Decreased or stable | 20 | 9.3–30.8 | 0.143 |
| Increased | 4 | 0–21.4 | |
|
| |||
| Time form liver metastasis to treatment | |||
| ≤4 months | 24 | 7.5–40.5 | 0.102 |
| >4 months | 6 | 2.5–9.5 | |
|
| |||
| Imaging response by mRECIST criteria | |||
| Responders | 9 | 0.0–28.1 | 0.753 |
| Non-responders | 9 | 0.0–19.7 | |
OS, overall survival; CI, confidence interval; MELD, model for end-stage liver disease; mRECIST, modified response evaluation criteria in solid tumors.